View in EDS HTML Full Text PDF Full Text

Assessing and mitigating pH-mediated DDI risks in drug development – formulation approaches and clinical considerations.

Saved in:
Bibliographic Details
Title: Assessing and mitigating pH-mediated DDI risks in drug development – formulation approaches and clinical considerations.
Authors: Wu, Di1 (AUTHOR) di.wu10@merck.com, Liu, Jiaying1 (AUTHOR), Paragas, Erickson M.2 (AUTHOR), Yadav, Jaydeep3 (AUTHOR), Aliwarga, Theresa2 (AUTHOR), Heimbach, Tycho1 (AUTHOR), Escotet-Espinoza, M. Sebastian1 (AUTHOR)
Source: Drug Metabolism Reviews. Aug2025, Vol. 57 Issue 3, p291-310. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:03602532
DOI:10.1080/03602532.2024.2345632